Telix Pharmaceuticals Limited
TLX
$9.08
-$0.28-2.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 161.27% | 158.89% | 423.29% | 519.33% | -9.56% |
| Total Receivables | 107.43% | 128.10% | 88.80% | 123.45% | 38.78% |
| Inventory | 71.42% | 181.41% | 100.05% | 136.77% | 145.03% |
| Prepaid Expenses | -- | -- | -19.02% | -4.16% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 194.34% | 138.31% | 12.82% | 33.52% | 56.52% |
| Total Current Assets | 133.70% | 148.50% | 258.67% | 324.49% | 16.69% |
|
|
|||||
| Total Current Assets | 133.70% | 148.50% | 258.67% | 324.49% | 16.69% |
| Net Property, Plant & Equipment | 190.62% | 251.16% | 61.73% | 91.41% | 66.12% |
| Long-term Investments | 136.52% | 5,732.96% | 1,897.53% | 2,264.11% | 2,027.14% |
| Goodwill | 136.52% | 5,732.96% | 1,897.53% | 2,264.11% | 2,027.14% |
| Total Other Intangibles | 111.92% | 467.15% | 168.06% | 217.25% | 430.09% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 356.84% | 404.29% | 423.53% | 519.61% | 366.62% |
| Total Assets | 139.09% | 324.38% | 239.12% | 301.36% | 140.96% |
|
|
|||||
| Total Accounts Payable | 247.35% | 273.35% | 89.93% | 124.79% | -34.19% |
| Total Accrued Expenses | 26.76% | 73.80% | 25.36% | 48.37% | 135.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 735.21% | 1,431.59% | 1,151.21% | 1,380.82% | 345.27% |
| Total Finance Division Other Current Liabilities | 53.87% | 241.48% | 98.71% | 135.18% | 108.59% |
| Total Other Current Liabilities | 53.87% | 241.48% | 98.71% | 135.18% | 108.59% |
| Total Current Liabilities | 73.20% | 204.53% | 82.00% | 115.40% | 81.60% |
|
|
|||||
| Total Current Liabilities | 73.20% | 204.53% | 82.00% | 115.40% | 81.60% |
| Long-Term Debt | 5,494.55% | 5,562.08% | 6,002.69% | 7,122.64% | 79.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 358.16% | 470.34% | -3.73% | 13.94% | 26.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 65.94% | 35.93% | -31.59% | -19.03% | -17.62% |
| Total Liabilities | 236.59% | 373.32% | 234.90% | 296.36% | 46.33% |
|
|
|||||
| Common Stock & APIC | 20.72% | 61.27% | 21.40% | 43.68% | 50.26% |
| Retained Earnings | 3.09% | 5.68% | 26.67% | 13.22% | 17.93% |
| Treasury Stock & Other | 198.78% | 758.76% | 596.88% | 688.06% | 263.94% |
| Total Common Equity | 56.55% | 257.15% | 246.42% | 309.99% | 432.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 56.55% | 257.15% | 246.42% | 309.99% | 432.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 56.55% | 257.15% | 246.42% | 309.99% | 432.46% |
|
|
|||||